NYR
Click for more information
1.75% 5.8¢ nyrada inc.

Ann: European Patent to be Granted for Cholesterol-Lowering Drug, page-10

  1. renn11
    101 Posts.
    lightbulb Created with Sketch. 8
    clock Created with Sketch.
    17/05/22
    13:11
    Post #: 61452922
    Main reason for the overselling is due to the China lockdowns impacting the company contracted to produce the drug. Not a fundamental sell down in any way, just market sentiment. At the current price this is a screaming buy.
    NYR Price at posting: 19.3¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 7  Upvote
    lightbulb Created with Sketch. 1  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

PH2 Pure Hydrogen to supply hydrogen-fuelled garbage truck to City of Newcastle
right-arrow Created with Sketch.
LYC Lynas eyes first dysprosium, terbium HREE production in CY25
right-arrow Created with Sketch.
NEWS Microcap Wrap: 5 explorers with news out today
right-arrow Created with Sketch.
CMX ChemX Materials kicks off first stage works at WA high purity alumina pilot
right-arrow Created with Sketch.
NEWS Tenant turnover: Reducing costs and revenue-loss
right-arrow Created with Sketch.
3DP Pointerra wins US$1.63M from US Dept of Energy to model climate change scenarios
right-arrow Created with Sketch.
watchlist Created with Sketch. Add NYR (ASX) to my watchlist
(20min delay)
Last
5.8¢ 		Change
0.001(1.75%) 		Mkt cap ! $10.38M
Open High Low Value Volume
5.8¢ 5.8¢ 5.7¢ $2.588K 44.90K

Buyers (Bids)

No. Vol. Price($)
3 72440 5.7¢
 

Sellers (Offers)

Price($) Vol. No.
5.8¢ 3365 1
View Market Depth
Last trade - 13.20pm 28/06/2024 (20 minute delay) ?
NYR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.